Title:
ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF, AND PHARMACEUTICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/088386
Kind Code:
A1
Abstract:
The present application discloses the antibodies or antigen-binding fragments, and their pharmaceutical use. In particular, a monoclonal antibody according to the present application suppresses tumors, and can thus be useful as a cancer therapeutic agent and in targeted cancer treatments including the detection of various cancers, and the delivery of drugs to specific cancers, etc
Inventors:
LIN TSUNG YI (US)
HUANG PEGGY (US)
LO LARRY (US)
HUANG PEGGY (US)
LO LARRY (US)
Application Number:
PCT/CN2023/127107
Publication Date:
May 02, 2024
Filing Date:
October 27, 2023
Export Citation:
Assignee:
HANSOH BIO LLC (US)
SHANGHAI HANSOH BIOMEDICAL CO LTD (CN)
CHANGZHOU HANSOH PHARMACEUTICAL CO LTD (CN)
SHANGHAI HANSOH BIOMEDICAL CO LTD (CN)
CHANGZHOU HANSOH PHARMACEUTICAL CO LTD (CN)
International Classes:
C07K16/28; A61K39/395; A61P35/00; C07K16/30; C12N1/19; C12N1/21; C12N5/10; G01N33/574
Domestic Patent References:
| WO2011044311A2 | 2011-04-14 | |||
| WO2012156532A1 | 2012-11-22 | |||
| WO2014159915A1 | 2014-10-02 | |||
| WO2016040622A1 | 2016-03-17 | |||
| WO2019241893A2 | 2019-12-26 |
Foreign References:
| US20150210766A1 | 2015-07-30 |
Attorney, Agent or Firm:
GE CHENG & CO., LTD. (CN)
Download PDF: